Centene Corporation: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-10-16
Other years: 2026 vs 2025 · 2025 vs 2024
⚠ AI Risk Brief Interpretation layer — deterministic data below

Centene added three major risks: pharma costs, vendor accountability, and competitive adaptation. Removed pandemic and disruption concerns.

Direction ↑ More concerning
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

3
New Risks
3
Removed
15
Modified
15
Unchanged
🟢 New in Current Filing Disclosure change9/10

If our vendors fail to meet their contractual obligations to us or fail to comply with applicable laws or regulations, our results of operations may be adversely affected and we may be exposed to brand and reputational harm, litigation and/or regulatory action.

🟢 New in Current Filing Increases in our pharmaceutical costs could have a material adverse effect on the level of our medical costs and our results of operations. 🔒
🟡 Modified If we fail to comply with applicable data privacy and security laws, regulations, rules, standards and contractual obligations, including with respect to third-party service providers that utilize sensitive personal information on our behalf, our business, reputation, results of operations, financial condition and cash flows could be materially and adversely affected. 🔒
🟢 New in Current Filing We operate in a highly competitive, dynamic and rapidly evolving industry and our failure to adapt could negatively impact our business. 🔒

And 17 more changes in the full comparison.

20 changes in this historical filing

The complete historical comparison (2024 vs 2023) is available on the Pro plan.

Get Pro access Already a Pro subscriber? View full diff →